Because the world can’t afford another COVID-19, we are working with a coalition of partners to help the global community be ready next time. We build support for robust disease surveillance networks and rapid response systems that can protect against future outbreaks wherever they may arise.
Monalisa Chatterji, a senior program officer for the Bill & Melinda Gates Foundation’s Discovery & Translational Sciences team, works on the discovery of novel candidate therapeutics.
Interview with Trevor Mundel on COVID-19. Mundel leads the foundation’s efforts to develop high-impact interventions against the leading causes of death and disability in developing countries.
SEATTLE, March 10, 2020 – The Bill & Melinda Gates Foundation, Wellcome, and Mastercard today committed up to $125 million in seed funding to speed-up the response to the COVID-19…
We are joining forces with Wellcome and Mastercard to beef up our COVID-19 response—backed by $125 million in both new funding and money already earmarked to tackle this epidemic. The…
SEATTLE March 4, 2020 – The Bill & Melinda Gates Foundation announced today that it will commit an additional $5 million to help public health agencies in the greater Seattle…
Interview with Ken Duncan on COVID-19 (novel coronavirus). Duncan leads drug discovery efforts for the Bill & Melinda Gates Foundation’s Discovery & Translational Sciences team.
Interview with Valerie Nkamgang Bemo on COVID-19. Bemo manages the Bill & Melinda Gates Foundation’s investments that support communities affected by natural disasters and complex emergencies.
SEATTLE, February 5, 2020 – The Bill & Melinda Gates Foundation today announced that it will immediately commit up to $100 million for the global response to the 2019 novel…
SEATTLE, January 26, 2020 – The Bill & Melinda Gates Foundation today announced that it is immediately committing $10 million in emergency funds and corresponding technical support to help frontline…
